https://www.rizerecovery.com/newsroom/medetomidine-withdrawal-naloxone-icu-what-providers-need-2026 Rize Newsroom en 2026-10-05T13:48:20.776Z Naloxone Won't Touch Medetomidine. The Withdrawal That Follows Can Land Someone in the ICU for Weeks. https://www.rizerecovery.com/newsroom/no-approved-stimulant-drug-contingency-management-works-2026 Rize Newsroom en 2026-10-05T13:48:17.560Z Three Hundred and Seventy-One Trials Later, There Is Still No Approved Drug for Meth or Cocaine. The Best Treatment We Have Is a Gift Card. https://www.rizerecovery.com/newsroom/nicotine-pouches-withdrawal-searchlights-fda-authorizations-spotlight-2026 Rize Newsroom en 2026-10-05T13:48:14.303Z The FDA Keeps Clearing Nicotine Pouches. The Writer Who Quit One Cold Turkey Saw Searchlights. https://www.rizerecovery.com/newsroom/one-in-32-young-people-opioid-medication-six-months-2026 Rize Newsroom en 2026-10-05T13:48:10.930Z Only 1 in 32 Young People With Opioid Addiction Is Still on Medication Six Months Later. The Treatment Didn't Fail Them. https://www.rizerecovery.com/newsroom/minnesota-refocus-recovery-peer-support-medicaid-lawsuit-2026 Rize Newsroom en 2026-10-04T13:47:32.497Z Minnesota Sues the Founder of a Peer Recovery Nonprofit It Calls a Sham. Hundreds of Peers Lost Their Jobs First. https://www.rizerecovery.com/newsroom/dea-7-oh-kratom-schedule-i-withdrawal-gap-2026 Rize Newsroom en 2026-10-04T13:47:29.427Z The DEA Wants 7-OH in Schedule I. Nobody Has Said What Happens to the People Taking It Today. https://www.rizerecovery.com/newsroom/psychedelics-fda-hearing-workforce-gap-spotlight-2026 Rize Newsroom en 2026-10-04T13:47:26.044Z Eighteen Thousand People Registered to Watch the FDA Plan Psychedelic Medicine. Almost No University Teaches How to Give It.